Latest AI and machine learning research in leukemia for healthcare professionals.
The phase 2 LUNAR trial randomized (1:1) patients with oligorecurrent hormone-sensitive prostate cancer to neoadjuvant [177Lu]Lu-PSMA-I&T (2 cycles, 6.8 GBq) followed by stereotactic body radiotherapy (SBRT) versus SBRT alone. [177Lu]Lu-PSMA-I&T before SBRT was well tolerated and significantly improved PSMA PET/CT-based progression-free survival compared with SBRT alone. Here, we report the estima...
The unprecedented success of mRNA vaccines during the COVID-19 pandemic has accelerated the development of nucleic acid-based therapeutics, particularly in oncology. Decades of foundational research on mRNA design, delivery, and immunogenicity have laid the groundwork for the application of mRNA vaccines in cancer treatment. Herein, we summarize the key principles of synthetic mRNA engineering, in...
BACKGROUND: Machine learning (ML) can be used to predict clinical outcomes. Training predictive models typically requires data for hundreds or thousan...
Genome annotation currently requires performing dozens of molecular assays in hundreds of cell and tissue samples, an expensive endeavor which is impr...
BACKGROUND: Primary cardiac malignancies are rare and highly aggressive, with limited clinical evidence to guide optimal treatment. This study evaluat...
Osteosarcoma, the most common primary malignant bone tumour, presents significant treatment challenges due to its complex tumour microenvironment and ...
Cardiac arrhythmia is increasingly encountered in patients with cancer, not only as a result of shared risk factors but also as a direct consequence o...
Accurate, non-invasive liver fibrosis detection is essential for chronic liver disease management, particularly with rising metabolic dysfunction-asso...
UNLABELLED: Neutropenic fever (NF) is often the first sign of infection in patients with hematologic malignancies, but its cause is frequently unknown...
PURPOSE: Sarcopenia has already been widely investigated as a potential indicator of negative outcomes in oncology patients. Our aim was to evaluate t...
Accurate subtyping of acute leukemia is essential for guiding therapy and predicting patient outcomes. Morphological assessment remains challenging fo...
Cancer remains a leading cause of death worldwide, with lineage plasticity emerging as a hallmark that drives therapy resistance and tumor progression...
BACKGROUND: Glioblastoma (GBM), the most prevalent and aggressive primary brain tumor in adults, has a median survival of merely 14 months. Current th...
Psychological treatments are increasingly being developed and delivered using platforms such as mobile applications, online modules, virtual reality, ...
Leukemia diagnostics have changed significantly because of the advancements in biosensor technologies that improve the early detection, sensitivity, a...
MOTIVATION: Single-cell RNA sequencing (scRNA-seq) data analysis is often performed using network projections that produce co-expression networks. The...
This study investigates the use of quantitative LC-MS/MS-based proteomics and surface-enhanced Raman spectroscopy (SERS) for biomarker detection in cl...
Recent studies have highlighted the impact of copper-induced cell death (cuproptosis) on cancer progression, prognosis, and treatment, but it remains ...
Large scale sequencing efforts have defined up to 27 diagnostic entities in B-ALL, leaving few samples without subtype assignment. Extended genomic an...
Bulk RNA sequencing (RNA-seq) deconvolution typically uses single-cell RNA sequencing (scRNA-seq) references, but some cells are only detectable throu...